Emergence of Herpes Simplex Virus-1 Syncytial Variants With Altered Virulence for Mice After Selection With a Natural Carrageenan
暂无分享,去创建一个
E. Damonte | F. Linero | L. Scolaro | M. Artuso | Cecilia G. Mateu | G. Hermida | M. J. Carlucci | Cecilia G. Mateu | Mercedes Perez Recalde | María C. Artuso | Carlos A. Pujol | C. A. Pujol | Mercedes Pérez Recalde
[1] J. Burgos,et al. ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice , 2006, Journal of NeuroVirology.
[2] K. Tyler,et al. Pathogenesis of Viral Infections , 2010 .
[3] N. de Vos,et al. Monitoring of herpes simplex virus in the lower respiratory tract of critically ill patients using real-time PCR: a prospective study. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[4] B. Friedland,et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.
[5] J. Davis,et al. Effect of IL-6 deficiency on susceptibility to HSV-1 respiratory infection and intrinsic macrophage antiviral resistance. , 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[6] A. Gettie,et al. Efficacy of Carraguard®-Based Microbicides In Vivo Despite Variable In Vitro Activity , 2008, PloS one.
[7] R. Maguire. Microbicide product development , 2008, Current opinion in HIV and AIDS.
[8] V. Smit,et al. Quantitative detection of herpes simplex virus DNA in the lower respiratory tract , 2007, Journal of medical virology.
[9] H. Agut,et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. , 2007, American journal of respiratory and critical care medicine.
[10] D. Phillips,et al. Carrageenan/MIV-150 (PC-815), a Combination Microbicide , 2007, Sexually transmitted diseases.
[11] M. Smyth,et al. NK cells contribute to the early clearance of HSV‐1 from the lung but cannot control replication in the central nervous system following intranasal infection , 2006, European journal of immunology.
[12] E. De Clercq,et al. Characterization of Herpes Simplex Virus Type 1 Thymidine Kinase Mutants Selected under a Single Round of High-Dose Brivudin , 2005, Journal of Virology.
[13] B. Lina,et al. Herpes Simplex Virus Thymidine Kinase Mutations Associated with Resistance to Acyclovir: a Site-Directed Mutagenesis Study , 2005, Antimicrobial Agents and Chemotherapy.
[14] F. B. Johnson,et al. Identification of syncytial mutations in a clinical isolate of herpes simplex virus 2. , 2004, Virology.
[15] T. Quinn,et al. The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping Epidemics , 2004, Journal of acquired immune deficiency syndromes.
[16] J. Sasadeusz,et al. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. , 2004, Antiviral research.
[17] Wiley Interscience,et al. Herpes simplex type 1 shedding is associated with reduced hospital survival in patients receiving assisted ventilation in a tertiary referral intensive care unit , 2004, Journal of medical virology.
[18] L. Stanberry,et al. Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? , 2003, Sexually transmitted diseases.
[19] M. Arsenakis,et al. A single amino acid substitution in the cytoplasmic tail of the glycoprotein B of herpes simplex virus 1 affects both syncytium formation and binding to intracellular heparan sulfate. , 2003, Virus research.
[20] D. Thouvenot,et al. Herpes simplex virus resistance to antiviral drugs. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[21] E. Damonte,et al. Herpes simplex virus type 1 variants arising after selection with an antiviral carrageenan: Lack of correlation between drug susceptibility and syn phenotype , 2002, Journal of medical virology.
[22] Jian Liu,et al. Cell surface heparan sulfate and its roles in assisting viral infections , 2002, Medicinal research reviews.
[23] B. Svennerholm,et al. Herpes Simplex Virus Types 1 and 2 Differ in Their Interaction with Heparan Sulfate , 2000, Journal of Virology.
[24] M. Levin,et al. Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria , 2000, Critical care medicine.
[25] A. Wald,et al. Herpes simplex virus: the importance of asymptomatic shedding. , 2000, The Journal of antimicrobial chemotherapy.
[26] E. Damonte,et al. Inhibitory Action of Natural Carrageenans on Herpes simplex Virus Infection of Mouse Astrocytes , 1999, Chemotherapy.
[27] E. Damonte,et al. Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. , 1999, Antiviral research.
[28] J. Platt,et al. Regulation of platelet heparanase during inflammation: Role of pH and proteinases , 1998, Journal of cellular physiology.
[29] Hao Wang,et al. Syndecans, Heparan Sulfate Proteoglycans, Maintain the Proteolytic Balance of Acute Wound Fluids* , 1998, The Journal of Biological Chemistry.
[30] G. Darby,et al. Survey of Resistance of Herpes Simplex Virus to Acyclovir in Northwest England , 1998, Antimicrobial Agents and Chemotherapy.
[31] L. Corey,et al. Perspectives on switching oral acyclovir from prescription to over-the-counter status: report of a consensus panel. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] E. Damonte,et al. Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity. , 1997, International journal of biological macromolecules.
[33] P. Spear,et al. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition. , 1996, Virology.
[34] D. Falke,et al. Single amino acid substitutions in the glycoprotein B carboxy terminus influence the fusion from without property of herpes simplex virus type 1. , 1995, The Journal of general virology.
[35] N. Davis-Poynter,et al. Mutations in the cytoplasmic tail of herpes simplex virus glycoprotein H suppress cell fusion by a syncytial strain , 1994, Journal of virology.
[36] J. Verhoef,et al. Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A. , 1992, The Journal of biological chemistry.
[37] J. L. Goodman,et al. Altered pathogenesis in herpes simplex virus type 1 infection due to a syncytial mutation mapping to the carboxy terminus of glycoprotein B , 1991, Journal of virology.
[38] B. Herold,et al. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity , 1991, Journal of virology.
[39] P. Spear,et al. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate , 1989, Journal of virology.
[40] M. Sarmiento. Intrinsic resistance to viral infection. Mouse macrophage restriction of herpes simplex virus replication. , 1988, Journal of immunology.
[41] J. Sodroski,et al. Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus , 1987, Nature.
[42] P. Lazo. Pathogenesis of viral infections. , 1985, The New England journal of medicine.
[43] J. A. Bradley,et al. Herpes simplex virus reactivation in surgical patients , 1984, Critical care medicine.
[44] P. Spear,et al. Alterations in Glycoprotein gB Specified by Mutants and Their Partial Revertants in Herpes Simplex Virus Type 1 and Relationship to Other Mutant Phenotypes , 1980, Journal of virology.